Nucleus accumbens shell: A potential target for drug-resistant epilepsy with neuropsychiatric disorders

Epilepsy Res. 2020 Aug:164:106365. doi: 10.1016/j.eplepsyres.2020.106365. Epub 2020 May 12.

Abstract

The nucleus accumbens (NAc) is an important component of the ventral striatum, involving motivational and emotional processes, limbic-motor interfaces. Recently, experimental and clinical data have shown that NAc, particularly NAc shell (NAcs), participates in ictogenesis and epileptogensis in drug-resistant epilepsy (DRE). Therefore, we summarize the existing literature on NAcs and potential role in epilepsy, from the bench to the clinic. Connection abnormalities between NAcs and remainings, degeneration of NAc neurons, and an aberrant distribution of neuroactive substances have been reported in patients with DRE. These changes may be underlying the pathophysiological mechanism of the involvement of NAcs in DRE. Furthermore, alterations in NAcs may also be involved in neuropsychiatric disorders in patients with DRE. These observational studies demonstrate the multiple properties of NAcs and the complex relationship between the limbic system and DRE with neuropsychiatric disorders. NAcs can be a potential target for DBS and stereotactic lesioning to manage DRE with neuropsychiatric disorders. Future studies are warranted to further clarify the role of NAcs in epilepsy.

Keywords: Deep brain stimulation; Drug-Resistant epilepsy; Neuropsychological disorders; Nucleus accumbens shell.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain / physiopathology
  • Deep Brain Stimulation* / methods
  • Drug Resistant Epilepsy / complications
  • Drug Resistant Epilepsy / physiopathology*
  • Drug Resistant Epilepsy / therapy*
  • Humans
  • Neurons / physiology
  • Nucleus Accumbens / physiopathology*
  • Pharmaceutical Preparations / metabolism

Substances

  • Pharmaceutical Preparations